<DOC>
	<DOCNO>NCT02979561</DOCNO>
	<brief_summary>A prospective randomise control study evaluate outcome treatment pradaxa warfarin prevention recurrent DVT patient angiographically confirm acute massive pulmonary embolism undergoIng endovascular mechanical fragmentation thrombolytic therapy . [ RE-SPIRE study ]</brief_summary>
	<brief_title>Pradaxa Warfarin Prevention Recurrent VTE Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation Thrombolytic Therapy</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Fibrinolytic Agents</mesh_term>
	<criteria>Men woman age &gt; 18 year Angiographically confirm acute massive pulmonary embolism involvement Central pulmonary artery . endovascular mechanical thrombus fragmentation + thrombolytic therapy ( use recombinant tissue activator plasminogen ) , perform treatment abovementioned pulmonary embolism le 48 hour randomization . The patient randomize earlier 24 hour procedure endovascular mechanical thrombus fragmentation + thrombolytic therapy Written inform consent sign patient . Signs hemodynamic instability ( i.e . systolic blood pressure &lt; 100 mm Hg.St . episode systolic blood pressure fall â‰¥40 mm Hg . / heart rate &gt; 110 last 15 min ) need ventilatory support within 12 hour prior randomisation . The indication oral anticoagulation , associate others disease . malignant neoplasm location Contraindications warfarin pradaxa accord Russian Instructions medical use drug Indications concomitant treatment antiplatelet agent Any stroke within 6 month randomization Intracranial hemorrhage anamnesis Active bleeding , bleed diathesis . Clinically significant bleeding within last 30 day . Trauma extensive surgery within 1 month randomization surgery plan next 6 month randomization . Intracranial pathology : tumor , arteriovenous fistula aneurysm . Gastrointestinal bleed previous 3 month . Gastric ulcer duodenal ulcer clinical manifestation endoscopically identify acute ulcer without sign scar previous 30 day . Uncontrolled hypertension ( systolic blood pressure &gt; 180 mm Hg . / diastolic blood pressure &gt; 100 mm.hg patient receive antihypertensive drug ) . Pregnancy , lactation . Life expectancy &lt; 6 month . Clinically significant liver disease . Creatinine clearance ( estimate CockcroftGault ) &lt; 30 ml / min . hemoglobin level &lt; 90 g/l ) , thrombocytopenia &lt; 100x10^9 / L. Patients , opinion researcher , suitable inclusion study , example , due low likelihood doctor 's recommendation follow . Longterm use NSAIDs Current participation another clinical study . Allergic contrast substance radioisotope drug use procedure assess endpoint study , accord researcher , may contraindication implementation research method .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Dabigatran etexilate</keyword>
	<keyword>Recurrence DVT</keyword>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Warfarin</keyword>
</DOC>